Phase IIIB Switching From Intravenous to Subcutaneous Study

Clinical trial NCT00663702 · COMPLETED

Trial details

NCT number: NCT00663702
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Arthritis, Rheumatoid

Start date: 2008-05-01
Primary completion: 2009-12-01
Enrollment: 123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.